ROUGHT PHARM CO.LTD.
ROUGHT PHARM CO.LTD.

Product Classification

The company is committed to serving the fields of medicine, pesticide, biology and materials. Its main business includes: new drug research and development outsourcing services, customized research and development and production of pharmaceutical, pesticide, biological and material intermediates, generic drugs and bulk fine products process development and optimization...

Linkers for the solid-phase synthesis of amino acids and peptides

Linkers for the solid-phase synthesis of amino acids and peptides
Pharmaceutical intermediates

Pharmaceutical intermediates
Bridge ring compounds

Bridge ring compounds
OLED material intermediates

OLED material intermediates
API

API
Pyrrole and tetrahydropyrrole

Pyrrole and tetrahydropyrrole
pyridine

pyridine
Organic boric acid

Organic boric acid
Small rings (ternary and quaternary)

Small rings (ternary and quaternary)

About Us

Chengdu Ruihede Pharmaceutical (est. 2018) established subsidiary Deyang Ruihede Pharmaceutical in 2021.

Specializing in pharmaceutical/agrochemical/biotech/material sectors, core services:

• Novel drug CRO

• Custom intermediates R&D and production

• Generic drug & fine chemicals process optimization

The company has been certified as a National High-Tech Enterprise and has obtained ISO 9001:2015 certification and holds more than 30 patents.

Click to learn more
Company Profile

Company Profile

Team Strength

Team Strength

Company core concept

Company Core Philosophy

Contact Us

Product Center

Contact Us

Contact Us

PRODUCTS CENTER

The main business includes: new drug research and development outsourcing services, pharmaceutical, pesticide, biological and material intermediates customized research and development and production.

199174-29-3

199174-29-3
120737-78-2

120737-78-2
90950-44-0 (non-salt)

90950-44-0 (non-salt)
50606-31-0

50606-31-0
167102-62-7

167102-62-7
33420-52-9

33420-52-9
75344-77-3

75344-77-3
309915-46-6

309915-46-6
7499-66-3

7499-66-3
112245-13-3

112245-13-3

NEWS CENTER

Welcome to the company's latest news and industry information

The API market ushered in volume, and a large number of enterprises are accelerating the expansion of production capacity Article link: Pharmaceutical Network https://www.zyzhan.com/news/detail/81957.html

The API market ushered in volume, and a large number of enterprises are accelerating the expansion of production capacity Article link: Pharmaceutical Network https://www.zyzhan.com/news/detail/81957.html

09-01

2021

The sword points to a $3 billion space! The development of BCL-2 is timely

The B lymphocytoma-2 gene (Bcl-2) plays an important role in apoptosis and is one of the factors that cause hematologic tumors. At present, for the research and development of Bcl-2 target, AbbVie's Venetoclax has been listed in 2016, and domestic Ascentage Pharma, BeiGene, Fosun Pharma, etc. have also laid out this target. In this paper, by analyzing the layout of Bcl-2, we explore the future development direction of this target.

09-01

2021

391 pharmaceutical companies posted their report cards in the first half of the year, and 18 had gross profit margins of more than 90%

Pharmaceutical Network on September 1 Up to now, a total of 391 A-share pharmaceutical companies have disclosed their performance in the first half of 2021, and more than seventy percent of the company's performance (revenue and net profit) have both risen.

08-24

2021

Introduction of wholly-owned subsidiary - Deyang Rui and Dede Pharmaceutical Technology Co., Ltd

Deyang Rui Hede Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary, was officially established on March 29, 2021, and the company's factory in Deyang was officially started in March 2021, and it is planned to enter the trial stage within the year.

08-24

2021

The official website of Chengdu Ruihede Pharmaceutical Technology Co., Ltd. is online!

The official website of Chengdu Ruihede Pharmaceutical Technology Co., Ltd. is online!

Service Hotline:

18183292809

Sales mailbox:

sales@ruihede.com

Address:

Floor 1-2, Building 13, No. 188, West Section of Kexing Road, Wenjiang District, Chengdu

Focus on us

Focus on us

COPYRIGHT©2023 RUIHEDE PHARMACEUTICAL TECHNOLOGY CO., LTD. ALL RIGHTS RESERVED.  POWER BY：300.cn·Chengdu

SAF Coolest v1.3 设置面板GFFSX-ZNIR-QVAFE-AAS

营业执照及SEO链接： Business License

无数据提示

Sorry, the current column has no content for the time being.!

You can view other columns or returnHome Page

SVG图标库请自行添加图标，用div包起来，并命名使用